What is the survival rate of stage 2 lymphoma?

What is the survival rate of stage 2 lymphoma?

For stage II the 5-year survival rate is close to 76% and for stage III it is more than 70%. For stage IV NHL, the 5-year survival rate is around 63%. These survival rates vary depending on the cancer’s stage and subtype.

Can you get leukemia after lymphoma?

Some survivors of Hodgkin lymphoma have a higher risk of developing a secondary cancer, especially acute myeloid leukemia (after certain types of chemotherapy, like BEACOPP, or radiation therapy), non-Hodgkin lymphoma, lung cancer, or breast cancer.

Is leukemia and lymphoma curable?

Leukemia and lymphoma are both types of cancer that affect white blood cells and the immune system. However, they differ in the way they affect the body. Treatment with chemotherapy, radiation therapy, and targeted therapy can all help manage these conditions and, in some cases, cure them.

What is the difference between lymphoma and leukemia?

The main difference between lymphocytic leukemias and lymphomas is that in leukemia, the cancer cells are mainly in the bone marrow and blood, while in lymphoma they tend to be in lymph nodes and other tissues.

Is Stage 2 lymphoma curable?

Stage of disease– Stage I or II can offer good prognosis, though later stages may be highly treatable as well. No lymphoma outside of lymph nodes, or lymphoma in only one area outside of lymph nodes.

Are lymphoma and leukemia related?

Leukemias and lymphomas are often grouped together. The reason this is so is that they are both considered “blood-related” cancers. This is in contrast to “solid tumors” such as breast cancer or lung cancer.

What is the most common treatment for both lymphoma and leukemia?

Leukemia and Lymphoma Treatment You, your primary care doctor and your hematologist/oncologist develop the best care plan for you and your disease. Typically, the main treatment for both diseases is chemotherapy. Sometimes a treatment plan can include targeted therapy drugs, radiation therapy or surgery.